Identifying antiviral protein IFN-γ as a potential biomarker for Long COVID

SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. New research shows that in Long COVID patients, IFN-y production persists until symptoms improve, highlighting a potential biomarker and a target for therapies.

Banner & Foodsmart Offer Free Groceries, Meals & Nutrition Help in Arizona

What You Should Know: Banner – University Family Care announced a new partnership with Foodsmart, the nation’s largest food benefits management company. The partnership supports the

March 15, 2024

FDA approves Astellas’ gastric cancer drug Vyloy ahead of schedule

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 19, 2024

Data on AstraZeneca cancer drug allay safety concerns but treatment still faces questions

MADRID — Questions about one of AstraZeneca’s key cancer drug candidates — and the dribs and drabs that have come out about its performance —

October 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.